Immunopathology and human mast cell cytokines

Critical Reviews in Oncology/Hematology

Volumn 31, Issue 2, 1999, Pages 119-133

  Bradding, Peter ^a   Holgate, Stephen T ^b  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; CYTOKINE; HEPARIN; HISTAMINE; IMMUNOGLOBULIN E; PROTEINASE; PROTEOGLYCAN; TRYPTASE;

ALLERGY; ANAPHYLAXIS; ANGIOGENESIS; ANTIGEN PRESENTATION; BLOOD VESSEL; CELL REGENERATION; CONNECTIVE TISSUE; EPITHELIUM CELL; FIBROBLAST; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; MAST CELL; REVIEW;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; MAST CELLS;

EID: 0032816815     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(99)00010-4     Document Type: Review

References (137)

1. Church M.K., Okayama Y., Bradding P. Functional mast cell heterogeneity. Busse W.W., Holgate S.T. Asthma and Rhinitis. 1994;209-220 Blackwell, Oxford.
2. Bradding P., Walls A.F., Church M.K. Mast cells and basophils: their role in initiating and maintaining inflammatory responses. Holgate S.T. Immunopharmacology of the Respiratory System. 1995;53-84 Academic Press, New York.
3. Chung S.W., Wong P.M., Shen-Ong G. et al. Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood. 68:1986;1074-1081.
4. Brown M.A., Pierce J.H., Watson C.J. et al. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell. 50:1987;809-818.
5. Plaut M., Pierce J.H., Watson C.J. et al. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 339:1989;64-67.
6. Wodnar-Filipowicz A., Heusser C.H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature. 339:1989;150-152.
7. Burd P.R., Rogers H.W., Gordon J.R. et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:1989;245-257.
8. Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 346:1990;274-276.
9. Leal-Berumen I., Conlon P., Marshall J.S. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152:1994;5468-5476.
10. Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science. 258:1992;1957-1959.
11. Hogaboam C., Kunkel S.L., Strieter R.M. et al. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J. Immunol. 160:1998;6166-6171.
12. Walsh L.J., Trinchieri G., Waldorf H.A. et al. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. US. 88:1991;4220-4224.
13. Bradding P., Feather I.H., Howarth P.H. et al. Interleukin 4 is localised to and released by human mast cells. J. Exp. Med. 176:1992;1381-1386.
14. Wershil B.K., Wang Z.S., Gordon J.R. et al. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 87:1991;446-453.
15. Bradding P., Feather I.H., Wilson S. et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL- 4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151:1993;3853-3865.
16. Bradding P., Roberts J.A., Britten K.M. et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:1994;471-480.
17. Bradding P., Mediwake R., Feather I.H. et al. TNF alpha is localised to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin. Exp. Allergy. 25:1995;406-415.
18. Bradding P., Feather I.H., Wilson S. et al. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am. J. Respir. Crit. Care Med. 151:1995;1900-1906.
19. Bradding P., Okayama Y., Howarth P.H. et al. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155:1995;297-307.
20. Horsmanheimo L., Harvima I.T., Jarvikallio A. et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br. J. Dermatol. 131:1994;348-353.
21. Ying S., Humbert M., Barkans J. et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+and CD8+T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:1997;3539-3544.
22. Cook EB, Stahl JL, Graziano FM, et al. Human conjunctival mast cells stain positive for the cytokines IL-4, IL-5, and TNFα by intracellular FACS analysis. J Allergy Clin Immunol 99:S91, 1997. (Abstract).
23. Okayama Y., Petit-Frere C., Kassel O. et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J. Immunol. 155:1995;1796-1808.
24. Jaffe J.S., Glaum M.C., Raible D.G. et al. Human lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation. Am. J. Respir. Cell Mol. Biol. 13:1995;665-675.
25. Ying S., Durham S.R., Jacobson M.R. et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology. 82:1994;200-206.
26. Ying S., Durham S.R., Corrigan C.J. et al. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:1995;477-487.
27. Ying S., Durham S.R., Barkans J. et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am. J. Respir. Cell Mol. Biol. 9:1993;356-360.
28. Moller A., Lippert U., Lessmann D. et al. Human mast cells produce IL-8. J. Immunol. 151:1993;3261-3266.
29. Jaffe J.S., Raible D.G., Post T.J. et al. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am. J. Respir. Cell Mol. Biol. 15:1996;473-481.
30. Rumsaeng V., Cruikshank W.W., Foster B. Human mast cells produce the CD4+T lymphocyte chemoattractant factor, IL-16. J. Immunol. 159:1997;2904-2910.
31. Qu Z., Liebler J.M., Powers M.R. et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am. J. Pathol. 147:1995;564-573.
32. Reed J.A., Albino A.P., McNutt N.S. Human cutaneous mast cells express basic fibroblast growth factor. Lab. Invest. 72:1995;215-222.
33. Yano K., Yamaguchi M., de Mora F. et al. Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE- dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77:1997;185-193.
34. Okayama Y., Kobayashi H., Ashman L.K. Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation. Eur. J. Immunol. 28:1998;708-715.
35. Baghestanian M., Hofbauer R., Kiener H.P. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. Blood. 90:1997;4438-4449.
36. Zhang S., Anderson D.F., Bradding P. et al. Human mast cells express stem cell factor. J. Pathol. 186:1998;59-66.
37. Reshef A., MacGlashan D.W. Immunogold probe for the light-microscopic phenotyping of human mast cells and basophils. J. Immunol. Methods. 99:1987;213-219.
38. Ormerod A.D., Herriot R., Davidson R.J. Adult mastocytosis: an immunophenotypic and flow-cytometric investigation. Br. J. Dermatol. 122:1990;737-744.
39. Suzumura Y., Ohasi M. Immunoelectron microscopic localisation of HLA-DR antigen on mast cells and vessels in normal and tuberculin-reactive skin. Am. J. Dermatopathol. 13:1991;568-574.
40. Frandji P., Oskeritzian C., Cacaraci F. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151:1993;6318-6328.
41. Love K.S., Lakshmanan R.R., Butterfield J.H. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Cell Immunol. 170:1996;85-90.
42. Frandji P., Oskeritzian C., Cacaraci F. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151:1993;6318-6328.
43. Fox C.C., Jewell S.D., Whitacre C.C. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol. 158:1994;253-264.
44. Frandji P., Tkaczyk C., Oskeritzian C. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+T lymphocytes. Eur. J. Immunol. 26:1996;2517-2528.
45. Frandji P., Tkaczyk C., Oskeritzian C. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol. 163:1995;37-46.
46. Frandji P., Mourad W., Tkaczyk C. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signalling pathway. Eur. J. Immunol. 28:1998;844-854.
47. Huels C., Germann T., Goedert S. Co-activation of naive CD4+T cells and bone marrow-derived mast cells results in the development of Th2 cells. Int. Immunol. 7:1995;525-532.
48. Nogami M., Suko M., Okudaira H. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am. Rev. Respir. Dis. 141:1990;1289-1295.
49. Brusselle G.G., Kips J.C., Tavernier J.H. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy. 24:1994;73-80.
50. Kung T.T., Stelts D., Zurcher J.A. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 12:1995;404-409.
51. Takeda K., Hamelmann E., Joetham A. et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186:1997;449-454.
52. Yoshimoto T., Paul W.E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1994;1285-1295.
53. Matzinger P. Tolerance, danger, and the extended family. Ann. Rev. Immunol. 12:1994;991-1045.
54. Askenase P.W., Van Loveren H., Kraeuter-Kops S. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J. Immunol. 131:1983;2687-2694.
55. Van Loveren H., Meade R., Askenase P.W. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J. Exp. Med. 157:1983;1604-1617.
56. Thomas W.R., Schrader J.W. et al. Delayed hypersensitivity in mast-cell-deficient mice. J. Immunol. 130:1983;2565-2567.
57. Galli S.J., Hammel I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science. 226:1984;710-713.
58. Dudler T., Machado D.C., Kolbe L. et al. A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. J. Immunol. 155:1995;2605-2613.
59. Machado D.C., Horton D., Harrop R. et al. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitisation with antigen-specific IgE. Eur. J. Immunol. 26:1996;2972-2980.
60. Gauchat J.F., Henchoz S., Mazzei G. et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 365:1993;340-343.
61. Pawankar R., Okuda M., Yssel H. et al. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99:1997;1492-1499.
62. Saito H, Nakajima T, Tachimoto H, et al. Upregulation of FcεRIα by IgE molecules on human cultured mast cells and basophils. J Allergy Clin Immunol 99:S103, 1997. (Abstract).
63. Welker P, Grabbe J, Zuberbier T, et al. IgE upregulates expression of the high affinity IgE receptor FcεRI on human mast cells. J Allergy Clin Immunol 99:S103, 1997. (Abstract).
64. Toru H, Ra C, Nonoyama S, et al. Induction of high affinity IgE receptor (FcεRI) on human mast cells by IL-4. J Allergy Clin Immunol 99:S103, 1997. (Abstract).
65. Xia H-Z, Irani AA, Klisch G, et al. Recombinant human (rh) IL-4 induces FcεRI on rhSCF-dependent fetal liver-derived human mast cells. J Allergy Clin Immunol 99:S104, 1997. (Abstract).
66. Yamaguchi M., Lantz C.S., Oettgen H.C. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE- dependent reactions. J. Exp. Med. 185:1997;663-672.
67. Bonfanti R., Furie B.C., Furie B. et al. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood. 73:1989;1109-1112.
68. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
69. Moser R., Fehr J., Bruijnzeel P.L. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149:1992;1432-1438.
70. Ebisawa M., Bochner B.S., Georas S.N. et al. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J. Immunol. 149:1992;4021-4028.
71. Klein L.M., Lavker R.M., Matis W.L. et al. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 86:1989;8972-8976.
72. Meng H., Tonnesen M.G., Marchese M.J. et al. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J. Cell Physiol. 165:1995;40-53.
73. Okayama Y., Kobayashi H., Ashman L.K. et al. Activation of eosinophils with cytokines produced by lung mast cells. Int. Arch. Allergy. Immunol. 1(Suppl. 114):1997;75-77.
74. Levi-Schaffer F., Temkin V., Malamud V. et al. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. J. Immunol. 160:1998;5554-5562.
75. Dolovich J., Hargreave F.E., Chalmers R. et al. Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy. Clin. Immunol. 52:1973;38-46.
76. Solley G.O., Gleich G.J., Jordon R.E. et al. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J. Clin. Invest. 58:1976;408-420.
77. Gounni A.S., Lamkhioued B., Ochiai K. et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature. 367:1994;183-186.
78. Humbert M., Grant J.A., Taborda-Barata L. et al. High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am. J. Respir. Crit. Care Med. 153:1996;1931-1937.
79. Atkins P., Green G.R., Zweiman B. Histologic studies of human skin test responses to ragweed, compound 48-80, and histamine. J. Allergy. Clin. Immunol. 51:1973;263-273.
80. James M.P., Kennedy A.R., Eady R.A. et al. A microscopic study of inflammatory reactions in human skin induced by histamine and compound 48/80. J. Invest. Dermatol. 78:1982;406-413.
81. Fahy J.V., Fleming H.E., Wong H.H. et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am. J. Respir. Crit. Care Med. 155:1997;1828-1834.
82. Boulet L.P., Chapman K.R., Cote J. et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am. J. Respir. Crit. Care Med. 155:1988;1835-1840.
83. Wershil B.K., Murakami T., Galli S.J. Mast cell-dependent amplification of an immunologically non-specific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J. Immunol. 140:1988;2356-2360.
84. Matsuda H., Kawakita K., Kiso Y. et al. Substance P induces granulocyte infiltration through degranulation of mast cells. J. Immunol. 142:1989;927-931.
85. Tannenbaum S., Oertel H., Henderson W. et al. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J. Immunol. 125:1980;325-335.
86. Coyle A.J., Wagner K., Bertrand C. et al. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183:1996;1303-1310.
87. Mirza H., Schmidt V.A., Derian C.K. et al. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood. 90:1997;3914-3922.
88. Clark J.M., Abraham W.M., Fishman C.E. et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am. J. Respir. Crit. Care Med. 152:1995;2076-2083.
89. Woodbury R.G., Miller H.R., Huntley J.F. et al. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature. 312:1984;450-452.
90. Madden K.B., Urban J.F.J., Ziltener H.J. et al. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147:1991;1387-1391.
91. Malaviya R., Ikeda T., Ross E. et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 381:1996;77-80.
92. Echtenacher B., Mannel D.N., Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381:1996;75-77.
93. Heard B.E., Dewar A., Corrin B. Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis. Ultrastructure and cell perimeter measurements. J. Pathol. 166:1992;303-310.
94. Kawanami O., Ferrans V.J., Fulmer J.D. et al. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 40:1979;717-734.
95. Casale T.B., Trapp S., Zehr B. et al. Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases. Am. Rev. Respir. Dis. 138:1988;1604-1608.
96. Broide D.H., Smith C.M., Wasserman S.I. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. J. Immunol. 145:1990;1838-1844.
97. Goto T., Befus D., Low R. et al. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am. Rev. Respir. Dis. 130:1984;797-802.
98. Watanabe S., Watanabe K., Oishi T. et al. Mast cells in the rat alveolar septa undergoing fibrosis after ionising irradiation. Ultrastructural and histochemical studies. Lab. Invest. 31:1974;555-567.
99. Wagner M.M., Edwards R.E., Moncrieff C.B. Mast cells and inhalation of asbestos in rats. Thorax. 39:1984;539-544.
100. Suzuki N., Horiuchi T., Ohta K. et al. Mast cells are essential for the full development of silica-induced pulmonary inflammation: a study with mast cell-deficient mice. Am. J. Respir. Cell Mol. Biol. 9:1993;475-483.
101. Hawkins R.A., Claman H.N., Clark R.A. et al. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med. 102:1985;182-186.
102. Nishioka K., Kobayashi Y., Katayama I. Mast cell numbers in diffuse scleroderma. Arch. Dermatol. 123:1987;205-208.
103. Seibold J.R., Giorno R.C., Claman H.N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheumatism. 33:1990;1702-1709.
104. Falanga V., Soter N.A., Altman R.D. et al. Elevated plasma histamine levels in systemic sclerosis (scleroderma). Arch. Dermatol. 126:1990;336-338.
105. Walker M., Harley R., Maize J. et al. Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc. Soc. Exp. Biol. Med. 180:1985;323-328.
106. Walker M.A., Harley R.A., LeRoy E.C. Inhibition of fibrosis in TSK mice by blocking mast cell degranulation. J. Rheumatol. 14:1987;299-301.
107. Subba Rao P.V., Friedman M.M., Atkins F.M. et al. Phagocytosis of mast cell granules by cultured fibroblasts. J. Immunol. 130:1983;341-349.
108. Franzen, Norrby K. Local mitogenic effect of tissue mast cell secretion. Cell Tissue Kinetics. 13:1980;635-642.
109. Roche W.R. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. Am. J. Pathol. 119:1985;57-64.
110. Boucek R.J., Noble N.L. Histamine, norepinephrine, and bradykinin stimulation of fibroblast growth and modification of serotonin response. Proc. Soc. Exp. Biol. Med. 144:1973;929-933.
111. Jordana M., Befus A.D., Newhouse M.T. et al. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax. 43:1988;552-558.
112. Sandberg N. Accelerated collagen formation and histamine. Nature. 194:1962;183-185.
113. Hatamochi A., Fujiwara K., Ueki H. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch. Dermatol. Res. 277:1985;60-64.
114. Piguet P.F., Grau G.E., Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am. J. Pathol. 136:1990;103-110.
115. Sugarman B.J., Aggarwal B.B., Hass P.E. et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 230:1985;943-945.
116. Vilcek J., Palombella V.J., Henriksen-DeStefano D. et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med. 163:1986;632-643.
117. Dayer J.M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:1985;2163-2168.
118. Yoffe J.R., Taylor D.J., Wooley D.E. Mast cell products stimulate collagenase and prostaglandin E production by cultures of adherent rheumatoid synovial cells. Biochem. Biophys. Res. Comm. 122:1984;270-276.
119. Inoue Y., King T.E.J., Tinkle S.S. et al. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am. J. Pathol. 149:1996;2037-2054.
120. Gospodarowicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J. Cell Physiol. 128:1986;475-484.
121. Yayon A., Klagsbrun M., Esko J.D. et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
122. Folkman J., Klagsbrun M., Sasse J. et al. A heparin-binding angiogenic protein basic fibroblast growth factor is stored within basement membrane. Am. J. Pathol. 130:1988;393-400.
123. Yamashita Y., Nakagomi K., Takeda T. et al. Effect of heparin on pulmonary fibroblasts and vascular cells. Thorax. 47:1992;634-639.
124. Monroe J.G., Haldar S., Prystowsky M.B. et al. Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation. Clin. Immunol. Immunopathol. 49:1988;292-298.
125. Postlethwaite A.E., Seyer J.M. Fibroblast chemotaxis induction by human recombinant interleukin- 4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J. Clin. Invest. 87:1991;2147-2152.
126. Postlethwaite A.E., Holness M.A., Katai H. et al. Human fibroblasts synthesise elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 90:1992;1479-1485.
127. Trautmann A., Feuerstein B., Ernst N. et al. Heterotypic cell-cell adhesion of human mast cells to fibroblasts. Arch. Dermatol. Res. 289:1997;194-203.
128. Trautmann A., Krohne G., Brocker E.B. et al. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4. J. Immunol. 160:1998;5053-5057.
129. Ruoss S.J., Hartmann T., Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88:1991;493-499.
130. Cairns J.A., Walls A.F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 99:1997;1313-1321.
131. Gruber B.L., Marchese M.J., Suzuki K. et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84:1989;1657-1662.
132. Westphal E. Ueber mastzellen. Ehrlich P. Farbenanalytische Untersuchungen zur Histologie und Klinik des Blutes. 1891;17 Verlag von Hirschwald, Berlin.
133. Hartveit F. Mast cells and metachromasia in human breast cancer: their occurrence, significance and consequence: a preliminary report. J. Pathol. 134:1981;7-11.
134. Rizzo V., DeFouw D.O. Mast cell activation accelerates the normal rate of angiogenesis in the chick chorioallantoic membrane. Microvasc. Res. 52:1996;245-257.
135. Dethlefsen S.M., Matsuura N., Zetter B.R. Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis. 14:1994;395-408.
136. Grutzkau A., Kruger-Krasagakes S., Baumeister H. et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol. Biol. Cell. 9:1998;875-884.
137. Blair R.J., Meng H., Marchese M.J. et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Invest. 99:1997;2691-2700.